Literature DB >> 11602731

Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone.

T J Chambers1, M Nickells.   

Abstract

A neuroadapted strain of yellow fever virus (YFV) 17D derived from a multiply mouse brain-passaged virus (Porterfield YF17D) was additionally passaged in SCID and normal mice. The virulence properties of this virus (SPYF) could be distinguished from nonneuroadapted virus (YF5.2iv, 17D infectious clone) by decreased average survival time in SCID mice after peripheral inoculation, decreased average survival time in normal adult mice after intracerebral inoculation, and occurrence of neuroinvasiveness in normal mice. SPYF exhibited more efficient growth in peripheral tissues of SCID mice than YF5.2iv, resulting in a more rapid accumulation of virus burden, but with low-titer viremia, at the time of fatal encephalitis. In cell culture, SPYF was less efficient in replication than YF5.2iv in all cell lines tested. The complete nucleotide sequence of SPYF revealed 29 nucleotide substitutions relative to YF5.2iv, and these were distributed throughout the genome. There were a total of 13 predicted amino acid substitutions, some of which correspond to known differences among the Asibi, French viscerotropic virus, French neurotropic vaccine, and YF17D vaccine strains. The envelope (E) protein contained five substitutions, within all three functional domains. Substitutions were also present in regions encoding the NS1, NS2A, NS4A, and NS5 proteins and in the 3' untranslated region (UTR). Construction of YFV harboring all of the identified coding nucleotide substitutions and those in the 3' UTR yielded a virus whose cell culture and pathogenic properties, particularly neurovirulence and neuroinvasiveness for SCID mice, generally resembled those of the original SPYF isolate. These findings implicate the E protein and possibly other regions of the genome as virulence determinants during pathogenesis of neuroadapted YF17D virus in mice. The determinants affect replication efficiency in both neural and extraneural tissues of the mouse and confer some limited host-range differences in cultured cells of nonmurine origin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602731      PMCID: PMC114671          DOI: 10.1128/JVI.75.22.10912-10922.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein.

Authors:  S Bhardwaj; M Holbrook; R E Shope; A D Barrett; S J Watowich
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.

Authors:  C S Hahn; J M Dalrymple; J H Strauss; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

3.  Effects of thorotrast on humoral antibody, viral multiplication, and interferon during infection with St. Louis encephalitis virus in mice.

Authors:  T P Monath; E C Borden
Journal:  J Infect Dis       Date:  1971-03       Impact factor: 5.226

4.  Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution.

Authors:  C M Rice; E M Lenches; S R Eddy; S J Shin; R L Sheets; J H Strauss
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

5.  Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence.

Authors:  M Lobigs; R Usha; A Nestorowicz; I D Marshall; R C Weir; L Dalgarno
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

6.  Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties.

Authors:  T J Chambers; A Nestorowicz; P W Mason; C M Rice
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Variation in virulence for mice and rhesus monkeys among St. Louis encephalitis virus strains of different origin.

Authors:  T P Monath; C B Cropp; G S Bowen; G E Kemp; C J Mitchell; J J Gardner
Journal:  Am J Trop Med Hyg       Date:  1980-09       Impact factor: 2.345

8.  The in vivo differentiation of strains of yellow fever virus in mice.

Authors:  R Fitzgeorge; C J Bradish
Journal:  J Gen Virol       Date:  1980-01       Impact factor: 3.891

9.  Isolation of plaque variants differing in virulence from the 17D strain of yellow fever virus.

Authors:  F Liprandi
Journal:  J Gen Virol       Date:  1981-10       Impact factor: 3.891

10.  Comparison of neurovirulence of different strains of yellow fever virus in mice.

Authors:  A D Barrett; E A Gould
Journal:  J Gen Virol       Date:  1986-04       Impact factor: 3.891

View more
  18 in total

1.  ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy.

Authors:  Juan Arroyo; Chuck Miller; John Catalan; Gwendolyn A Myers; Marion S Ratterree; Dennis W Trent; Thomas P Monath
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 2.  West Nile virus and its emergence in the United States of America.

Authors:  Kristy O Murray; Eva Mertens; Philippe Despres
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

3.  Genetic determinants of Sindbis virus mosquito infection are associated with a highly conserved alphavirus and flavivirus envelope sequence.

Authors:  Dennis J Pierro; Erik L Powers; Ken E Olson
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

4.  E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence.

Authors:  Eva Lee; Mario Lobigs
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

5.  Neuroadapted yellow fever virus strain 17D: a charged locus in domain III of the E protein governs heparin binding activity and neuroinvasiveness in the SCID mouse model.

Authors:  Janice Nickells; Maria Cannella; Deborah A Droll; Yan Liang; William S M Wold; Thomas J Chambers
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

6.  Characterization of a small plaque variant of West Nile virus isolated in New York in 2000.

Authors:  Yongqing Jia; Robin M Moudy; Alan P Dupuis; Kiet A Ngo; Joseph G Maffei; Greta V S Jerzak; Mary A Franke; Elizabeth B Kauffman; Laura D Kramer
Journal:  Virology       Date:  2007-07-06       Impact factor: 3.616

7.  Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice.

Authors:  Michael Nickells; Thomas J Chambers
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  Characterization of Plaque Variants and the Involvement of Quasi-Species in a Population of EV-A71.

Authors:  Madiiha Bibi Mandary; Malihe Masomian; Seng-Kai Ong; Chit Laa Poh
Journal:  Viruses       Date:  2020-06-17       Impact factor: 5.048

Review 9.  Pathogenesis of flavivirus encephalitis.

Authors:  Thomas J Chambers; Michael S Diamond
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

Review 10.  The key amino acids of E protein involved in early flavivirus infection: viral entry.

Authors:  Tao Hu; Zhen Wu; Shaoxiong Wu; Shun Chen; Anchun Cheng
Journal:  Virol J       Date:  2021-07-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.